**Exhibit
      31.2**


**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      302 OF THE SARBANES-OXLEY ACT OF 2002**





I,
      Philip E. Barak, Chief Financial Officer certify that:




1.
                  I have reviewed this
        quarterly report on Form 10-QSB of Flagship Global Health, Inc. (the
        "Registrant");
 
 2.
                  Based on my
        knowledge, this report does not contain any untrue statement of a material
        fact
        or omit to state a material fact necessary to make the statements made, in
        light
        of the circumstances under which such statements were made, not misleading
        with
        respect to the period covered by this report;
 
 3.
                  Based on my
        knowledge, the financial statements, and other financial information included
        in
        this report, fairly present in all material respects the financial condition,
        results of operations and cash flows of the Registrant as of, and for, the
        periods presented in this report;
 
 4.
                  The Registrant's
        other certifying officer and I are responsible for establishing and maintaining
        disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
        and 15d-15(e)) and internal control over financial reporting (as defined
        in
        Exchange Act rules 13a-15(f) and 15d-15(f)) for the Registrant and
        have:
 
 (a) Designed
        such disclosure controls and procedures, or caused such disclosure controls
        and
        procedures to be designed under our supervision, to ensure that material
        information relating to the Registrant ,
        including its consolidated subsidiaries, is made known to us by others within
        those entities, particularly during the period in which this report is being
        prepared ;
 
 
 (b) Evaluated
        the effectiveness of the Registrant 's
        disclosure controls and procedures and presented in this report our conclusions
        about the effectiveness of the disclosure controls and procedures, as of
        the end
        of the period covered by this report based on such evaluation; and
  (c)
                  Disclosed in this
        report any change in the Registrant 's
        internal control over financial reporting that occurred during the Registrant 's
        most
        recent fiscal quarter (the Registrant 's
        fourth
        fiscal quarter in the case of an annual report) that has materially affected,
        or
        is reasonably likely to materially affect, the Registrant 's
        internal control over financial reporting; and
 
 5.
                  The Registrant's
        other certifying officer and I have disclosed, based on our most recent
        evaluation of internal control over financial reporting, to the Registrant's
        auditors and the audit committee of the Registrant's board of directors (or
        persons performing the equivalent functions):
 
 (a)
                  All significant
        deficiencies and material weaknesses in the design or operation of internal
        control over financial reporting which are reasonably likely to adversely
        affect
        the Registrant's ability to record, process, summarize and report financial
        information; and
 
 (b)
                  Any fraud, whether
        or not material, that involves management or other employees who have a
        significant role in the Registrant's internal control over financial
        reporting.
  Date:
                November 13,
                2007By: /s/ Philip E. BarakPhilip
                E. Barak, Chief Financial
                Officer